Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Although the incidence and prevalence of irAEs have been well characterized in the literature, less is known about the cumulative incidence rate of irAEs. We studied the cumulative incidence of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Nuzzo, Pier Vitale, Pond, Gregory R, Abou Alaiwi, Sarah, Nassar, Amin H, Flippot, Ronan, Curran, Catherine, Kilbridge, Kerry L, Wei, Xiao X, McGregor, Bradley A, Choueiri, Toni, Harshman, Lauren C, Sonpavde, Guru
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174062/
https://ncbi.nlm.nih.gov/pubmed/32234849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000371
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky